Predicted effects of hemoglobin A1c assay precision on a patient population distribution of serial hemoglobin A1c difference values

Douglas F. Stickle, Mark L. Seligman, James D. Landmark, Michael J. Quon

Research output: Contribution to journalArticle

Abstract

Background: Interpretation of serial measurements of % hemoglobin A1c includes an assessment of differences from preceding values (DHbA1c). We examined predicted effects of different assay precisions on an observed population distribution for DHbA1c. Methods: Primary data were 5260 DHbA1c values from sequential HbA1c measurement pairs obtained within 1 calendar year. Each DHbA1c was replaced by a distribution obtained from sampling each component HbA1c value according to a normal distribution characterized by a fixed coefficient of variation (CV) of either 1%, 3% or 5% (forming data sets A, B and C, respectively). Data sets B and C, with inferior precision, were compared with the reference data set A (highest precision). Results: Using DHbA1c bin widths of 0.5% HbA1c, differences in assay precision caused significant redistribution of numbers within bins. For instance, for CV = 5%, there was a 7.2% decrease in the number of results within the DHbA1c bin = (- 0.5 to ≤ 0.0)% compared with the number for CV = 1%, and a 6.4% increase in numbers of results for DHbA1c > 0.5. Conclusion: Different HbA1c assay CVs can significantly affect the fraction of patients within different clinical categorizations for DHbA1c and consequently may differently influence patient care recommendations.

Original languageEnglish (US)
Pages (from-to)201-205
Number of pages5
JournalClinica Chimica Acta
Volume378
Issue number1-2
DOIs
StatePublished - Mar 1 2007

Fingerprint

Population distribution
Bins
Assays
Hemoglobins
Demography
Normal Distribution
Normal distribution
Patient Care
Sampling
Datasets

Keywords

  • Diabetes
  • Glycated hemoglobin
  • Hemoglobin A1c
  • Point-of-care testing
  • Precision

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Predicted effects of hemoglobin A1c assay precision on a patient population distribution of serial hemoglobin A1c difference values. / Stickle, Douglas F.; Seligman, Mark L.; Landmark, James D.; Quon, Michael J.

In: Clinica Chimica Acta, Vol. 378, No. 1-2, 01.03.2007, p. 201-205.

Research output: Contribution to journalArticle

Stickle, Douglas F. ; Seligman, Mark L. ; Landmark, James D. ; Quon, Michael J. / Predicted effects of hemoglobin A1c assay precision on a patient population distribution of serial hemoglobin A1c difference values. In: Clinica Chimica Acta. 2007 ; Vol. 378, No. 1-2. pp. 201-205.
@article{129d3f30067a4e2da18c6e5390520664,
title = "Predicted effects of hemoglobin A1c assay precision on a patient population distribution of serial hemoglobin A1c difference values",
abstract = "Background: Interpretation of serial measurements of {\%} hemoglobin A1c includes an assessment of differences from preceding values (DHbA1c). We examined predicted effects of different assay precisions on an observed population distribution for DHbA1c. Methods: Primary data were 5260 DHbA1c values from sequential HbA1c measurement pairs obtained within 1 calendar year. Each DHbA1c was replaced by a distribution obtained from sampling each component HbA1c value according to a normal distribution characterized by a fixed coefficient of variation (CV) of either 1{\%}, 3{\%} or 5{\%} (forming data sets A, B and C, respectively). Data sets B and C, with inferior precision, were compared with the reference data set A (highest precision). Results: Using DHbA1c bin widths of 0.5{\%} HbA1c, differences in assay precision caused significant redistribution of numbers within bins. For instance, for CV = 5{\%}, there was a 7.2{\%} decrease in the number of results within the DHbA1c bin = (- 0.5 to ≤ 0.0){\%} compared with the number for CV = 1{\%}, and a 6.4{\%} increase in numbers of results for DHbA1c > 0.5. Conclusion: Different HbA1c assay CVs can significantly affect the fraction of patients within different clinical categorizations for DHbA1c and consequently may differently influence patient care recommendations.",
keywords = "Diabetes, Glycated hemoglobin, Hemoglobin A1c, Point-of-care testing, Precision",
author = "Stickle, {Douglas F.} and Seligman, {Mark L.} and Landmark, {James D.} and Quon, {Michael J.}",
year = "2007",
month = "3",
day = "1",
doi = "10.1016/j.cca.2006.11.022",
language = "English (US)",
volume = "378",
pages = "201--205",
journal = "Clinica Chimica Acta",
issn = "0009-8981",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Predicted effects of hemoglobin A1c assay precision on a patient population distribution of serial hemoglobin A1c difference values

AU - Stickle, Douglas F.

AU - Seligman, Mark L.

AU - Landmark, James D.

AU - Quon, Michael J.

PY - 2007/3/1

Y1 - 2007/3/1

N2 - Background: Interpretation of serial measurements of % hemoglobin A1c includes an assessment of differences from preceding values (DHbA1c). We examined predicted effects of different assay precisions on an observed population distribution for DHbA1c. Methods: Primary data were 5260 DHbA1c values from sequential HbA1c measurement pairs obtained within 1 calendar year. Each DHbA1c was replaced by a distribution obtained from sampling each component HbA1c value according to a normal distribution characterized by a fixed coefficient of variation (CV) of either 1%, 3% or 5% (forming data sets A, B and C, respectively). Data sets B and C, with inferior precision, were compared with the reference data set A (highest precision). Results: Using DHbA1c bin widths of 0.5% HbA1c, differences in assay precision caused significant redistribution of numbers within bins. For instance, for CV = 5%, there was a 7.2% decrease in the number of results within the DHbA1c bin = (- 0.5 to ≤ 0.0)% compared with the number for CV = 1%, and a 6.4% increase in numbers of results for DHbA1c > 0.5. Conclusion: Different HbA1c assay CVs can significantly affect the fraction of patients within different clinical categorizations for DHbA1c and consequently may differently influence patient care recommendations.

AB - Background: Interpretation of serial measurements of % hemoglobin A1c includes an assessment of differences from preceding values (DHbA1c). We examined predicted effects of different assay precisions on an observed population distribution for DHbA1c. Methods: Primary data were 5260 DHbA1c values from sequential HbA1c measurement pairs obtained within 1 calendar year. Each DHbA1c was replaced by a distribution obtained from sampling each component HbA1c value according to a normal distribution characterized by a fixed coefficient of variation (CV) of either 1%, 3% or 5% (forming data sets A, B and C, respectively). Data sets B and C, with inferior precision, were compared with the reference data set A (highest precision). Results: Using DHbA1c bin widths of 0.5% HbA1c, differences in assay precision caused significant redistribution of numbers within bins. For instance, for CV = 5%, there was a 7.2% decrease in the number of results within the DHbA1c bin = (- 0.5 to ≤ 0.0)% compared with the number for CV = 1%, and a 6.4% increase in numbers of results for DHbA1c > 0.5. Conclusion: Different HbA1c assay CVs can significantly affect the fraction of patients within different clinical categorizations for DHbA1c and consequently may differently influence patient care recommendations.

KW - Diabetes

KW - Glycated hemoglobin

KW - Hemoglobin A1c

KW - Point-of-care testing

KW - Precision

UR - http://www.scopus.com/inward/record.url?scp=33846904771&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846904771&partnerID=8YFLogxK

U2 - 10.1016/j.cca.2006.11.022

DO - 10.1016/j.cca.2006.11.022

M3 - Article

C2 - 17229418

AN - SCOPUS:33846904771

VL - 378

SP - 201

EP - 205

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

IS - 1-2

ER -